Alnemri et al., 1996; Martin et al., 1996
). To establish the molecular and cellular basis for these observations, we hypothesized that the release of proapoptotic mediators from mitochondria in response to granzyme B might be necessary for subsequent caspase processing and target cell death. The findings outlined below are consistent with this model and indicate that Bid-mediated mitochondrial disruption results in the release of multiple proapoptotic molecules that are necessary to achieve complete procaspase processing.
Figure 1. Granzyme B-Cleaved tBid Localizes to Mitochondria

Results and Discussion
Jurkat cells preincubated in medium containing either zVAD-fmk or the control inhibitor zFA-fmk (each 50 M) were exposed to sublytic perforin (P) alone or P with granzyme B (GrB, 50 nM) or in the Effective synergy between the two principal granule- takes place at Asp175, resulting in formation of a p20 heavy chain, which associates with the p10 light chain. The heavy chain is then autoprocessed further, near its amino-terminus at Asp9 and 28 to produce the more potent p19 and p17 forms (Fernandes-Alnemri et al., 1996). However, unlike what is observed when granzyme B is added to cytosolic extracts or purified procaspases, we found that extensive processing of procaspases by granzyme B did not take place in intact cells. A small proportion of the total cellular procaspase-3 was cleaved to produce the p20 species within 10 min of Jurkat cells being exposed to purified perforin/granzyme B (Figure 4 ). Further processing, with production of p19 was seen by 40 min. Preincubation of the cells with zVAD-fmk (but not FA-fmk) had no quantitative or kinetic effect on the appearance of the p20 fragment, but further processing was completely abolished. These results confirmed that granzyme B is able to initiate the processing of procaspase-3 directly, but further processing to fully active caspase-3 requires caspase autocatalysis. When Jurkat cells overexpressing Bcl-2 were exposed to granzyme B/perforin (Figure 5 ), similar early partial processing of procaspase-3 to the p20 form was ob- ure 5B). Consistent with our Western blot findings, minimal caspase-3 activity was detected in Jurkat.pgk cells at 15 min, when only the p20 form had been generated. tion of the p20 chain in Bcl-2-overexpressing Jurkat cells did not produce sufficient caspase-3 activity to By 30 or 45 min, specific caspase-3 activity had increased by about 20-fold, but this increase was comresult in cell death. The results for caspase-9 activity followed a very similar pattern, although substrate turnpletely inhibited in Jurkat.bcl2 cells. Therefore, genera-insufficient to kill Jurkat or NT2 cells. Our findings that further caspase processing is inhibited by zVAD-fmk also clearly indicate that the completion of caspase processing in cells dying in response to granzyme B is mediated by caspases themselves. Further caspase processing also stalls if Bcl-2 is overexpressed, as the release from mitochondria of three potent inducers of apoptosis, cytochrome c, Smac/Diablo, and HtrA2/Omi, is blocked.
In the absence of Bcl-2 overexpression, our data indicate a chain of events that progressively leads to caspase activation and cell death. These events can be divided into three phases: early, intermediate, and late (Figure 7) . Immediately upon reaching the cytosol (first 10 min, early phase) granzyme B performs two distinct functions. Its optimal substrate is Bid, and Bid cleavage after Asp75 is followed by tBid insertion into the mitochondrial outer membrane. In addition, granzyme B cleaves a small amount of procaspase-3 at Asp175, thereby sensitizing the caspase cascade for subsequent, more potent activation. We found no evidence that procaspase-9 is directly processed by granzyme In the early phase, destabilization of the mitochondrial membrane occurs in response to tBid, and the release of proapoptotic mediators commences. Our kinetic studies indicate cytochrome c release occurs within just over was generally much lower than for caspase-3 (Fig-2 Figure 6A ). Consistent caspase autoprocessing. Our data suggest that the with our findings in Jurkat cells, parental NT2 cells genmost crucial step is that Smac/Diablo and HtrA2/Omi erated both the p20 and p17 caspase-3 fragments, displace XIAP and similar inhibitors from procaspase-3, whereas only the p20 fragment was generated in permitting its autocatalysis. Although cytochrome c is MT2.Miha cells. These data indicated that caspase-3 released very early, we saw no evidence that caspase-9 activity in cells exposed to granzyme B/perforin is dicprocessing occurs prior to caspase-3 activation. Howtated by the balance of proapoptotic (Smac/Diablo, ever, we cannot totally exclude the possibility that casHtrA2/Omi) and antiapoptotic molecules (XIAP/Miha) pase-9 may be partly active in this phase, as it has been they express. Consistent with this proposition, we also shown that this caspase can have constitutive activity found that NT2.Miha cells transiently transfected to exin its unprocessed state (Srinivasula et al., 2001; Stenpress a cytoplasmic form of Smac that lacks a mitochonnicke et al., 1999). Ultimately, we believe it is likely that drial localization motif became able to process some all three proapoptotic mediators released from mitoprocaspase-3 to the p17 form ( Figure 6B) . chondria contribute significantly to cell death and that the question of which mediator is most important in any A Model of Caspase-Mediated Cell Death one cell type can only be resolved using cells derived Induced by Granzyme B from gene-disrupted mice as target cells. In the late Our current findings clearly show that granzyme B phase, the phenotypic changes typical of caspaselargely achieves caspase activation indirectly, rather mediated cell death take place. Activated caspase-3 is than by directly processing procaspases. Thus, the miable to cleave other procaspases and key downstream nor direct procaspase-3 processing that takes place substrates such as the inhibitor of caspase-activated DNase (iCAD) (Sakahira et al., 1998), leading to DNA within minutes of granzyme B reaching the cytosol is Upon entry into the cytosol from the endosomal compartment (early phase), granzyme B efficiently cleaves Bid at D75 and commences the partial processing of procaspase-3 at D175. XIAP binds to partially processed procaspase-3 (p20). All of these events take place when Bcl-2 is overexpressed in mitochondria; however, D75tBid is unable to induce the release of cytochrome c, Smac/Diablo, and HtrA2/Omi when Bcl-2 is overexpressed. In cells overexpressing Bcl-2, XIAP therefore remains bound to p20, a sufficient threshold of caspases activation is not reached, and the cells survive. By contrast, when low/normal levels of Bcl-2 are expressed, Smac/Diablo and HtrA2/Omi can displace XIAP from p20, permitting further caspase processing at D28 and D9 (intermediate phase). In the absence of Bcl-2 overexpression (Jurkat.pgk cells), full caspase processing (to p19 and p17) and activation occur in the late phase, leading to typical apoptosis which is manifested by changes including DNA fragmentation following cleavage of iCAD by caspase-3 and other activated caspases (see text for fuller details).
Experimental Procedures
fragmentation and the many other changes typical of apoptosis.
Cell Lines
We have shown that Bcl-2 overexpression potently (Trapani et al., 1993) . zVAD-fmk and zFA-fmk were purchased from Enzyme Systems Products. Jurkat, Jurkat.pgk, or rabbit anti-mouse or swine anti-rabbit reagent coupled to horseradish peroxidase after chemiluminescent amplification. Jurkat.bcl2 cells were exposed to perforin and granzyme B as described (Sutton et al., 2000) . In some experiments, the cells were treated with mouse anti-Fas IgM antibody (250 ng/ml CH11, Upstate Pulsed-Field Gel Electrophoresis High molecular weight DNA was prepared from 2 million Jurkat Biotechnology). Caspase activities were estimated by measuring turnover in colorimetric assays of the substrates DEVD-pNA (cascells treated with various apoptotic stimuli, resolved through a 1% agarose/TBE gel by pulsed-field electrophoresis (Biorad CHEFpase-3) and LEHD-pNA (caspase-9) (Biomol Research Laboratories, Plymouth, PA).
Mapper, 1-30 s pulse, 6 V/cm, 14ЊC), transferred to a nylon membrane, and probed with 32 P-dATP-labeled human COT-1 DNA (100 ng, Gibco-BRL).
Cell Fractionation
To determine the subcellular location of tBid, 10 million Jurkat cells
